| Quantification of [18F]DPA-714 Binding in the Human Brain: Initial Studies in Healthy Controls and Alzheimer'S Disease Patients SSV Golla, R Boellaard, V Oikonen, A Hoffmann, BNM Van Berckel, ... Journal of Cerebral Blood Flow & Metabolism 35 (5), 766-772, 2015 | 123 | 2015 |
| Multitracer model for staging cortical amyloid deposition using PET imaging LE Collij, F Heeman, G Salvadó, S Ingala, D Altomare, A de Wilde, ... Neurology 95 (11), e1538-e1553, 2020 | 70 | 2020 |
| In vivo tau pathology is associated with synaptic loss and altered synaptic function EM Coomans, DN Schoonhoven, H Tuncel, SCJ Verfaillie, EE Wolters, ... Alzheimer's research & therapy 13, 1-13, 2021 | 58 | 2021 |
| The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study MHJ Hagens, SSV Golla, B Janssen, DJ Vugts, W Beaino, AD Windhorst, ... European journal of nuclear medicine and molecular imaging 47, 379-389, 2020 | 54 | 2020 |
| In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET MHJ Hagens, SV Golla, MT Wijburg, M Yaqub, D Heijtel, MD Steenwijk, ... Journal of neuroinflammation 15, 1-10, 2018 | 53 | 2018 |
| Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum T Timmers, R Ossenkoppele, EE Wolters, SCJ Verfaillie, D Visser, ... Alzheimer's research & therapy 11, 1-12, 2019 | 49 | 2019 |
| Quantification of Tau Load Using [18F]AV1451 PET SSV Golla, T Timmers, R Ossenkoppele, C Groot, S Verfaillie, P Scheltens, ... Molecular imaging and biology 19, 963-971, 2017 | 45 | 2017 |
| Connectivity in and around organizations: Waves, tensions and trade-offs DG Kolb, K Dery, M Huysman, A Metiu Organization Studies 41 (12), 1589-1599, 2020 | 41* | 2020 |
| Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease EE Wolters, R Ossenkoppele, SCJ Verfaillie, EM Coomans, T Timmers, ... European journal of nuclear medicine and molecular imaging 47, 2866-2878, 2020 | 38 | 2020 |
| Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising SSV Golla, M Lubberink, BNM van Berckel, AA Lammertsma, R Boellaard EJNMMI research 7, 1-12, 2017 | 33 | 2017 |
| Quantification of [18F]florbetapir: A test–retest tracer kinetic modelling study SSV Golla, SCJ Verfaillie, R Boellaard, SM Adriaanse, MD Zwan, ... Journal of Cerebral Blood Flow & Metabolism 39 (11), 2172-2180, 2019 | 32 | 2019 |
| Harmonisation of PET/CT contrast recovery performance for brain studies EE Verwer, SSV Golla, A Kaalep, M Lubberink, FHP van Velden, ... European journal of nuclear medicine and molecular imaging 48, 2856-2870, 2021 | 31 | 2021 |
| Parametric methods for [18F]flortaucipir PET SSV Golla, EE Wolters, T Timmers, R Ossenkoppele, ... Journal of Cerebral Blood Flow & Metabolism 40 (2), 365-373, 2020 | 28 | 2020 |
| A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus EE Wolters, SSV Golla, T Timmers, R Ossenkoppele, ... EJNMMI research 8, 1-5, 2018 | 28 | 2018 |
| Model selection criteria for dynamic brain PET studies SSV Golla, SM Adriaanse, M Yaqub, AD Windhorst, AA Lammertsma, ... EJNMMI physics 4, 1-10, 2017 | 27 | 2017 |
| Parametric binding images of the TSPO ligand 18F-DPA-714 SSV Golla, R Boellaard, V Oikonen, A Hoffmann, BNM van Berckel, ... Journal of Nuclear Medicine 57 (10), 1543-1547, 2016 | 27 | 2016 |
| Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals T Timmers, R Ossenkoppele, D Visser, H Tuncel, EE Wolters, ... Journal of Cerebral Blood Flow & Metabolism 40 (12), 2464-2474, 2020 | 26 | 2020 |
| Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man TF van der Doef, SSV Golla, PJ Klein, GM Oropeza-Seguias, RC Schuit, ... Journal of Cerebral Blood Flow & Metabolism 36 (6), 1111-1121, 2016 | 24 | 2016 |
| 15O-Water PET Study of the effect of imatinib, a selective platelet-derived growth factor receptor inhibitor, Versus Anakinra, an IL-1R antagonist, on water-perfusable tissue … M Lubberink, SSV Golla, M Jonasson, K Rubin, B Glimelius, J Sörensen, ... Journal of Nuclear Medicine 56 (8), 1144-1149, 2015 | 24 | 2015 |
| Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET D Visser, SSV Golla, SCJ Verfaillie, EM Coomans, RM Rikken, ... medRxiv, 2022.06. 02.22275916, 2022 | 23 | 2022 |
